It is though to be important in many types of cancer and is high expression of CD36 is correlated with cancer drug resistance, including irinotecan (Jiang et al., 2019; Drury et al., 2020; Gyamfi et al., 2021; Feng et al., 2023). Here, CD36 is linked to cancer.